vs
Alkermes plc.（ALKS）与Forestar Group Inc.（FOR）财务数据对比。点击上方公司名可切换其他公司
Alkermes plc.的季度营收约是Forestar Group Inc.的1.4倍（$384.5M vs $273.0M），Alkermes plc.净利率更高（12.8% vs 5.6%，领先7.2%），Forestar Group Inc.同比增速更快（9.0% vs -10.6%），Alkermes plc.自由现金流更多（$170.0M vs $-157.1M），过去两年Alkermes plc.的营收复合增速更高（4.8% vs -9.6%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
ALKS vs FOR — 直观对比
营收规模更大
ALKS
是对方的1.4倍
$273.0M
营收增速更快
FOR
高出19.6%
-10.6%
净利率更高
ALKS
高出7.2%
5.6%
自由现金流更多
ALKS
多$327.1M
$-157.1M
两年增速更快
ALKS
近两年复合增速
-9.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $273.0M |
| 净利润 | $49.3M | $15.4M |
| 毛利率 | 88.0% | 20.1% |
| 营业利润率 | 15.1% | 7.6% |
| 净利率 | 12.8% | 5.6% |
| 营收同比 | -10.6% | 9.0% |
| 净利润同比 | -66.3% | -6.7% |
| 每股收益（稀释后） | $0.29 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALKSFOR
| Q4 25 | $384.5M | $273.0M | ||
| Q3 25 | $394.2M | $670.5M | ||
| Q2 25 | $390.7M | $390.5M | ||
| Q1 25 | $306.5M | $351.0M | ||
| Q4 24 | $430.0M | $250.4M | ||
| Q3 24 | $378.1M | $551.3M | ||
| Q2 24 | $399.1M | $318.4M | ||
| Q1 24 | $350.4M | $333.8M |
净利润ALKSFOR
| Q4 25 | $49.3M | $15.4M | ||
| Q3 25 | $82.8M | $86.9M | ||
| Q2 25 | $87.1M | $32.9M | ||
| Q1 25 | $22.5M | $31.6M | ||
| Q4 24 | $146.5M | $16.5M | ||
| Q3 24 | $92.4M | $81.5M | ||
| Q2 24 | $91.4M | $38.7M | ||
| Q1 24 | $36.8M | $45.0M |
毛利率ALKSFOR
| Q4 25 | 88.0% | 20.1% | ||
| Q3 25 | 86.9% | 22.3% | ||
| Q2 25 | 87.3% | 20.4% | ||
| Q1 25 | 83.9% | 22.6% | ||
| Q4 24 | 85.6% | 22.0% | ||
| Q3 24 | 83.3% | 23.9% | ||
| Q2 24 | 84.6% | 22.5% | ||
| Q1 24 | 83.3% | 24.9% |
营业利润率ALKSFOR
| Q4 25 | 15.1% | 7.6% | ||
| Q3 25 | 22.6% | 16.9% | ||
| Q2 25 | 23.8% | 11.2% | ||
| Q1 25 | 4.5% | 11.6% | ||
| Q4 24 | 37.8% | 8.7% | ||
| Q3 24 | 27.7% | 19.7% | ||
| Q2 24 | 27.5% | 16.2% | ||
| Q1 24 | 12.4% | 17.6% |
净利率ALKSFOR
| Q4 25 | 12.8% | 5.6% | ||
| Q3 25 | 21.0% | 13.0% | ||
| Q2 25 | 22.3% | 8.4% | ||
| Q1 25 | 7.3% | 9.0% | ||
| Q4 24 | 34.1% | 6.6% | ||
| Q3 24 | 24.4% | 14.8% | ||
| Q2 24 | 22.9% | 12.2% | ||
| Q1 24 | 10.5% | 13.5% |
每股收益（稀释后）ALKSFOR
| Q4 25 | $0.29 | $0.30 | ||
| Q3 25 | $0.49 | $1.70 | ||
| Q2 25 | $0.52 | $0.65 | ||
| Q1 25 | $0.13 | $0.62 | ||
| Q4 24 | $0.88 | $0.32 | ||
| Q3 24 | $0.55 | $1.59 | ||
| Q2 24 | $0.53 | $0.76 | ||
| Q1 24 | $0.21 | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $211.7M |
| 总债务越低越好 | — | $793.2M |
| 股东权益账面价值 | $1.8B | $1.8B |
| 总资产 | $2.5B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.44× |
8季度趋势，按日历期对齐
现金及短期投资ALKSFOR
| Q4 25 | $388.6M | $211.7M | ||
| Q3 25 | $616.4M | $379.2M | ||
| Q2 25 | $521.2M | $189.2M | ||
| Q1 25 | $399.8M | $174.3M | ||
| Q4 24 | $291.1M | $132.0M | ||
| Q3 24 | $396.3M | $481.2M | ||
| Q2 24 | $535.1M | $359.2M | ||
| Q1 24 | $420.8M | $416.2M |
总债务ALKSFOR
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
股东权益ALKSFOR
| Q4 25 | $1.8B | $1.8B | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.5B | $1.6B | ||
| Q3 24 | $1.3B | $1.6B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | $1.3B | $1.5B |
总资产ALKSFOR
| Q4 25 | $2.5B | $3.2B | ||
| Q3 25 | $2.3B | $3.1B | ||
| Q2 25 | $2.3B | $3.1B | ||
| Q1 25 | $2.1B | $3.0B | ||
| Q4 24 | $2.1B | $3.0B | ||
| Q3 24 | $2.2B | $2.8B | ||
| Q2 24 | $2.2B | $2.7B | ||
| Q1 24 | $2.1B | $2.6B |
负债/权益比ALKSFOR
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $-157.0M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $-157.1M |
| 自由现金流率自由现金流/营收 | 44.2% | -57.5% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 3.45× | -10.19× |
| 过去12个月自由现金流最近4个季度 | $480.3M | $93.0M |
8季度趋势，按日历期对齐
经营现金流ALKSFOR
| Q4 25 | $170.1M | $-157.0M | ||
| Q3 25 | $101.7M | $256.3M | ||
| Q2 25 | $150.2M | $15.8M | ||
| Q1 25 | $98.8M | $-19.8M | ||
| Q4 24 | $190.4M | $-450.0M | ||
| Q3 24 | $81.6M | $119.2M | ||
| Q2 24 | $146.0M | $-61.7M | ||
| Q1 24 | $21.1M | $-59.2M |
自由现金流ALKSFOR
| Q4 25 | $170.0M | $-157.1M | ||
| Q3 25 | $84.4M | $255.6M | ||
| Q2 25 | $137.2M | $15.0M | ||
| Q1 25 | $88.7M | $-20.5M | ||
| Q4 24 | $180.6M | — | ||
| Q3 24 | $73.3M | $118.4M | ||
| Q2 24 | $138.9M | $-62.3M | ||
| Q1 24 | $12.8M | $-59.8M |
自由现金流率ALKSFOR
| Q4 25 | 44.2% | -57.5% | ||
| Q3 25 | 21.4% | 38.1% | ||
| Q2 25 | 35.1% | 3.8% | ||
| Q1 25 | 28.9% | -5.8% | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 19.4% | 21.5% | ||
| Q2 24 | 34.8% | -19.6% | ||
| Q1 24 | 3.6% | -17.9% |
资本支出强度ALKSFOR
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 4.4% | 0.1% | ||
| Q2 25 | 3.3% | 0.2% | ||
| Q1 25 | 3.3% | 0.2% | ||
| Q4 24 | 2.3% | 0.0% | ||
| Q3 24 | 2.2% | 0.1% | ||
| Q2 24 | 1.8% | 0.2% | ||
| Q1 24 | 2.4% | 0.2% |
现金转化率ALKSFOR
| Q4 25 | 3.45× | -10.19× | ||
| Q3 25 | 1.23× | 2.95× | ||
| Q2 25 | 1.72× | 0.48× | ||
| Q1 25 | 4.40× | -0.63× | ||
| Q4 24 | 1.30× | -27.27× | ||
| Q3 24 | 0.88× | 1.46× | ||
| Q2 24 | 1.60× | -1.59× | ||
| Q1 24 | 0.57× | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
